Market Wizard Monthly Premium Subscription is closed. Don't call or message for the same.

We are still open for Quarterly and Yearly Subscription.

Guys don't ask again and again for How to Find Newsletter. Just check in Files section of Market Wizard, you will find all Newsletter from Day 1.

MARKET WIZARD NEWSLETTER ISSUE 8

Fundamental Stocks

▶️V Guard
▶️KKCL
▶️Loyal Equipments
▶️Disa International

Technical Stocks

▶️Banco Products
▶️Everest Ind
▶️Maharashtra Seamless
▶️Ramco Ind
▶️Rossel Ind

TEAM MARKET WIZARD

Reliance Industries has made the announcement of the First Call Payment on Partly Paid Up Shares (RILPP IN)

Timelines

Record Date: May 12 , 2021 (Wednesday).

Payable from May 17, 2021 to May 31, 2021, both days inclusive.

First Call Amount : INR 314.25/share.

https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*

CDSL Q4FY21 (Cons – Audited)
Share price – 810

Total Revenue from ops at 103.1 Cr
59.9 Cr (71.88%) YoY |86.1 Cr (19.51%) QoQ

Year ended 344 Cr vs. 225 Cr (52.84%)

Net Profit of 51.6 Cr
28.1 Cr (82.11%) YoY 54.02 Cr (5.52%) QoQ

Year ended 201.2 Crs vs 106.7 Cr (89.71%)

EPS (in Rs) 4.95
2.74 YoY | 5.14 QoQ

Year ending EPS: .19.17 vs. 10.17

View: Strong result. YoY revenue and profit both have increased and QoQ revenue increased profit decreased due to other income impact which was recorded 7.1 Cr in Q4FY21 Vs. 17.1 Cr in Q4FY20.

Business Updates & Highlights

EBITDA in Q4FY21 is around INR 63.8 Cr Vs. 26.08 Cr in Q4FY20 Vs. 55.9 Cr in Q3FY20 therefore up by 144% in QoQ and 14.1% in QoQ.
EBITDA in FY21 was around INR 211.8 Cr Vs. 89.3 Cr in FY20. EBITDA Margin increased to 67% from 52% (FY 2019-20).

Company is basically two primary segment viz. Depository – 76.6% and Data entry and storage – 22.5%.

YoY and QoQ topline growth for Depository was around 75.6% and 16.1% respectively. YoY and QoQ bottomline growth for Depository was around 212% and 13.7% respectively (**Very Positive**)

YoY and QoQ topline growth for Data entry and storage was around 64.2% and 35.2% respectively. YoY and QoQ bottomline growth for Data entry and storage was around 71.4% and 20.2% respectively (**Positive**)

The Company in its meeting of Board of Directors held today recommended a final dividend of Rs. 9 per equity share

Financial
ROE and ROCE is around 15% and 19% respectively and book value per share is around INR 74 and share is trading around 1.9x of its book value. Company is currently trading at annualized PE of around 42 which is fair. Strong operating cash flow as of FY 2021 and it was 192.6 Cr Vs. 82.1 Cr in FY20 therefore its up by around 134% in YoY (**Very sound**)

Share view: Share price high 825 (52 week) and now 810. Central Depository Services (India) Limited operates as a securities depository in India. The Company offers service for a range of clients, such as depositary participants and other capital market intermediaries, corporates, capital market intermediaries, insurance companies and others.

Position: Long term investor should continue with this company if any correction will be good opportunity to add. Long term target can be 1250+

Opportunities
Strong quarterly performance and continoulsy posting outstanding numbers. Debt free company.

During the last financial year, 1.23 crore new active Beneficial Owners accounts were opened with CDSL taking the total number of active beneficial owners to 3.34 crores as on March 31, 2021.

In the quarter ended March 31, 2021, your company through its subsidiary CVL continued to generate capital market investor records under CVL and being the first and largest KYC Registration Agency (KRA) in the country

CDSL maintains and services 3.34 crore Demat accounts of Investors or Beneficial Owners (BOs) spread across India. These BOs are serviced by CDSL’s 592 Depository Participants (DPs) from over 20,600 locations.

Major shareholders of CDSL include BSE Limited, HDFC Bank, LIC and Standard Chartered Bank

CDSL has monopolistic business around 60% of depository account. Mainly discount brokerage includes Zerodha, Upstox, Sharekhan included with CDSL. Due to high growth by discount brokerage house CDSL growth is envitable.

Concern
Promoter holding is too low in the company and around 20% only.

Disclaimer: Views are shared based on market research and study and personal in nature. Others can take the different view and opinions. Please do the thoroughly study before enter or exit the shares.
RD Stock (“High Returns with Low Risk is the Key”)


https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*

Reliance Ind – Q4FY21 (Cons – Audited)

Total revenue from operations at 154,896 Cr
139,535 Cr (11.05%) YoY | 123,997 Cr (24.32%) QoQ

Year ending revenue 486,326 Cr Vs. 612,437 Cr (-20.58%)

Net Profit of 14,995 Cr
6,546 Cr (129.03%) YoY 14,894 Cr (0.44%) QoQ

Year ending profit 53,739 Cr Vs. 39,880 Cr (34.71%)

Before exceptional Item:
EPS (in Rs) 19.29
16.63 YoY |20.51 QoQ

Before exceptional item:
Year ending EPS 67.60 Vs. 70.19

View: Result is in line with the market expectation. YoY and QoQ revenue and profit both have increased although profit very marginally/flat increased in QoQ. Year ending profit increased due to exceptional gain in the tune of INR 5,642 Cr as against losses of around INR 4,444 corresponding previous year.

Business Updates & Highlights

EBITDA (Cons.) Q4FY21 was INR 26,602 crore Vs. 25,886 Cr Vs. 26,094 Cr in QoQ therefore up by 2.7% in YoY and up by 1.9% in QoQ.

EBITDA (Cons.) FY21 was INR 97,580 Cr Vs. 102,280 Cr in FY20 therefore declined by 4.3% in YoY.

Finance cost was around INR 4,044 Cr Vs. 6,064 Cr in YoY Vs. 4,326 Cr in QoQ therefore declined by 33% in YoY and declined by 6.5% in QoQ.

Exports (including deemed exports) from RIL’s India operations in Q4FY21 was INR 46,406 crore as against INR 31,569 crore in Q4FY20 therefore up by 46.9% in YoY. Export in FY21 was around 145,143 Cr Vs. 203,852 Cr therefore declined by 28.2% in YoY.

The capital expenditure for the year ended 31st March, 2021 was ₹ 79,667 crore ($ 10.9 billion) including exchange rate difference.

Reliance Jio
Revenue including access revenues for the quarter was INR 21,650 crore VS. 17,993 Cr in YoY Vs. 22,588 Cr in QoQ therefore declined by 20.3% in YoY and up by 5.3% in QoQ.

EBITDA for the quarter was INR 8,573 crore Vs. 6,289 Cr Vs. 8,488 Cr and increase of 36.3% in YoY and 1.1% in QoQ. EBITDA Margin was around 46.9% Vs. 40.9% Vs. 43.6% in QoQ.

Year ending EBITDA was around INR 32,359 Cr and EBITDA margin was around 44%.

Net profit in Q4FY21 was INR 3,508 Cr Vs 2,379 Cr in Q4FY20 Vs. 3,489 Cr in Q3FY21 therefore up by 47.4% in YoY and 0.83% in QoQ. FY21 Net profit was INR 12,537 Cr.

Total Customer base as on 31st March 2021 of 426.2 million. Largest customer base in country. Healthy gross addition of 31.2 million and net addition of 15.4 million during 4Q

RELIANCE JIO Q4FY21 ARPU RS 138.2 Vs. 151 in Q3FY21 therefore its declined.

Total wireless data traffic during the quarter of 16.7 Bn GB; 5.2% growth.

Reliance Retail

Revenue for the quarter was INR 41,296 crore Vs. 34,402 in YoY Vs. 33,018 Cr in QoQ therefore up by 20% in YoY and up by 25.1% in QoQ.

Revenue for the FY21 was around INR 139,077 Cr Vs. 146,272 Cr in FY20 therefore declined by 4.8% in YoY.

EBITDA for the quarter was INR 3,617 crore Vs. 2,557 Cr in YoY Vs. 3,087 Cr in QoQ therefore up by 41.4% in YoY and up by 17.2% in QoQ. EBITDA margin was around 8.8% Vs. 7.4% in YoY Vs. 9.3% in QoQ.

FY21 EBITDA was around INR 9,789 Cr Vs. 9,683 Cr in FY20 therefore up by 1.1% in YoY.

• The total store count stood at 12,711 stores, covering 33.8 million sq ft. at the end of the year. As operating curbs were lifted, new store openings resumed with 1,456 stores being added during the FY21. The business opened 826 stores during the quarter, higher than all previous quarters combined, reflecting the acceleration in the pace of new store expansion.

Grocery and Fashion & Lifestyle registered all-time high revenues and the strong growth in Consumer Electronics, was bolstered by higher Jio devices sales.

The business continued to set new records as it served over 1 million customers on the Republic Day sale activity, across stores and JioMart

3x growth in JioMart Kirana partnerships over last quarter with reach extended to 10 new cities and taking the count to 33 cities

Oils to Chemical business
Revenue of Q4FY21 was INR 101,080 Cr Vs. 96,732 Cr in YoY Vs. 83,838 Cr in QoQ therefore up by 4.4% in YoY and up by 20.7% in QoQ.

Revenue for FY21 was around INR 320,008 Cr Vs.451,008 Cr in FY20 therefore declined by 29% in YoY.

EBITDA of Q4FY21 was around INR 11,407 Cr Vs. 11,961 Cr in Q4FY20 Vs. 9,756 Cr in Q3FY21 therefore declined by 4.6% in YoY and up by 16.9% in QoQ.

EBITDA margin was around 11.3% Vs. 12.4% in YoY Vs. 11.6% in QoQ.

Segment Revenues for the O2C business declined by 29% to ₹ 320,008 crore on account of lower volumes and price realization across key products.

PP, PE and PVC prices strengthened during the quarter by 19%, 16% and 18% Q-o-Q respectively amidst limited availability from both domestic and deep-sea suppliers and healthy demand.

PP margins over propylene increased by 43% ($285/MT) and PVC margin over Naphtha / EDC increased by 9% ($682/MT) on Q-o-Q basis. PE margins over naphtha remained stable ($539/MT) during the quarter.

Media Business

Revenue for Q4FY21 was around INR 1,415 Cr Vs. 1,464 Cr in Q4FY20 Vs. 1,422 Cr in Q3FY21 therefore declined by 3.3% in YoY and up by 0.5% in QoQ.

EBITDA in Q4FY21 was around INR 279 Cr Vs. 225 Cr in YoY Vs. 324 Cr therefore up by 24% in YoY and declined by 13.8% in QoQ. EBITDA margin in Q4FY21 was around 19.7% Vs. 22.8% in YoY Vs.15.4% in QoQ.

Digital News business achieved a full-year break-even driven by accelerated revenue growth. Subscription product MoneyControl Pro and News18.com vernacular section were standout performers

Financial
ROE and ROCE is around 8% and 8.2% respectively and book value per share is around INR 1,104 per share and share is currently trading at 1.8x of its book value. Company is currently trading at annualized PE of 30 around which is average as per Industry benchmark. Promoter holding in the company is around 50.5% which is slightly increased by YoY and QoQ. FIIs and DIIs hold around 25.7% and 12.6% respectively. Operating cash flow as of March 2021 was INR 26,185 Vs. 94,877 Cr in March 2020

View Share price high 2,368 and now 1,994 . Reliance Industries Limited (RIL) is an Indian multinational conglomerate company. Reliance owns businesses across India engaged in energy, petrochemicals, textiles, natural resources, retail, and telecommunications.

Position: Strong support is INR 1900. Long term investor should continue with the company.

Opportunities
RIL has combined its refining and petrochemicals businesses into an integrated O2C segment, which is being transferred to a wholly owned subsidiary. This would allow RIL to pursue further opportunities for growth along with the possibility of strategic partnerships.

RIL is among the top global petrochemical manufacturers. It is the largest producer of paraxylene, and the second largest of polyester fibre. Moreover, it is the fourth largest producer of purified terephthalic acid (PTA) and the fifth largest of polypropylene. In India, RIL accounts for nearly half of the total domestic cracker (ethylene) capacity, and has a production share of more than 50% in the polymers (PE, PP and PVC) market. Its strong market position helps it operate its petrochemical plants at full capacity and also benefits from its large scale

Reliance JIO
With its aggressive customer acquisition strategy, RJIL has built a strong market position in a short time.
Total Customer base as on 31st March 2021 of 426.2 million. Largest customer base in country. Healthy gross addition of 31.2 million and net addition of 15.4 million during 4Q

The increasing proportion of higher growth consumer-oriented businesses of retail and digital services have helped diversify RIL away from its traditional refining and petrochemical businesses (or O2C business).

Reliance Retail Strong recovery in revenues with EBITDA. Store count at 12,711; added 826 stores in 4Q FY21. Largest fund raise in consumer/retail sector in India from marquee global investors ($6.4b, Rs 47,265 Crores for 10.09%. Record revenue performance; growth of 35% YoY. Digital + New Commerce now contribute 10% of sales2. Jio Mart Kirana: Extended service coverage to 10 new cities, now active in 33 cities.

Risk Reliance two main businesses Petrochemicals and Refining continuously declined in YoY and QoQ despite they were covered still covered 55% dependent on topline in this quarter. GRM ($/bbl) corrected in QoQ and YoY. In bottom line this segment covers around 50% and declined by more than 40% in YoY. Deal with Aramco is also put on hold and currently no clarity on this matter. Considerably large, debt-funded capex or acquisition weakening the capital structure. Net Debt to EBITDA ratio over 2.5 times which is high.


Disclaimer: Views are shared based on market research and study and personal in nature. Others can take the different view and opinions. Please do the thoroughly study before enter or exit the shares.
RD Stock (“High Returns with Low Risk is the Key”)


https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*

LIVE now
https://youtu.be/gx-OzwHpM9k

Motilal Oswal foundation has contributed about 4.50 crs for COVID relief this week-
310 oxygen concentrators in Maharashtra, Raj and Guj thru BJS
50 BIPAP ventilators to various hospitals thru Pune Platform PPCR
one ambulance to Nandurbar collector
200 GAS CYLINDERS to hospitals in Raj
Also working with Seva Bharti and Sonu Sood foundation.
Situation remain challenging. Let’s hope for the best.


https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*

https://wp.me/pd0eZY-Z2

When we have offered with lot many options then our mind gets confused about what things we looking for and that will result in postponing of selection or we selected the wrong option. That will create dissatisfaction after selecting an option.

Bloomberg: Buffett Calls SPACs a 'Killer,' Make Berkshire Less Competitive.
https://www.bloomberg.com/news/articles/2021-05-01/buffett-calls-spacs-a-killer-make-berkshire-less-competitive

Poonawalla flees India's 'aggression' to UK

Poonawalla hints that he may start producing in Britain and tells Martin Fletcher about threatening calls from the rich and powerful


Adar Poonawalla of the Serum Institute has arrived in Britain on business and to escape the desperate situation in India where Covid-19 is raging like “a tornado”
AVINASH GOWARIKER
Martin Fletcher
Saturday May 01 2021,

The phone calls are the worst thing, says Adar Poonawalla, the biggest manufacturer of vaccines in the world. They are incessant and very menacing, adds the man whose Serum Institute is producing 90 per cent of India’s Covid-19 vaccines at a time when the pandemic is rampaging through the second most populous country on Earth, causing fear, panic and death on an appalling scale.

The calls come from some of the most powerful men in India. They come from the chief ministers of Indian states, heads of business conglomerates and others demanding instant supplies of Covishield, as the AstraZeneca vaccine is known in India. “ ‘Threats’ is an understatement,” Poonawalla says. “The level of expectation and aggression is really unprecedented. It’s overwhelming. Everyone feels they should get the vaccine. They can’t understand why anyone else should get it before them.”

The calls begin cordially, but when Poonawalla explains that he cannot possibly meet the callers’ demands “the conversations go in a very different direction”, he says. “They are saying if you don’t give us the vaccine it’s not going to be good . . . It’s not foul language. It’s the tone. It’s the implication of what they might do if I don’t comply. It’s taking control. It’s coming over and basically surrounding the place and not letting us do anything unless we give in to their demands.”

The calls, and throngs of desperate people who gather outside the Serum Institute’s 100-acre, state-of-the-art campus in Pune, 90 miles east of Mumbai, explain why Poonawalla has been offered a government security detail, and why the campus now has round-the-clock police protection.

They are partly why Poonawalla flew to London to join his wife and two children hours before Britain banned travellers from India eight days ago. “I’m staying here an extended time because I don’t want to go back to that situation,” he says. “Everything falls on my shoulders but I can’t do it alone . . . I don’t want to be in a situation where you are just trying to do your job, and just because you can’t supply the needs of X, Y or Z you really don’t want to guess what they are going to do.”

He is also here on business. He says he is planning to start vaccine production in countries outside India. Would that include Britain? “There’s going to be an announcement in the next few days,” he replies coyly, but it is worth noting that Lord Udny-Lister, until recently one of Boris Johnson’s top aides, visited the Serum Institute in March, and that the prime minister was also due to visit it on his cancelled trip to India this week.

The Poonawalla's are now the sixth richest family in India with a jet-setting lifestyle to match. Poonawalla and his glamorous wife, Natasha, have luxurious homes in Pune, Mumbai and London, paintings by Picasso, Dali, Rembrandt and Rubens, private planes, a helicopter and a collection of 35 classic cars.

When Covid-19 appeared at the start of 2020 Poonawalla took a huge gamble. Long before he knew whether a vaccine would be forthcoming, he began dramatically expanding his production facilities and signed a deal to produce a billion doses of whatever the Oxford University-AstraZeneca researchers came up with.

He struck gold. By the time the AstraZeneca vaccine was approved in January he had increased his annual production capacity from 1.5 to 2.5 billion doses at a cost of $800 million, and stockpiled 50 million doses of Covishield. He began exporting to 68 developing countries — and Britain — because India itself appeared to have defeated the pandemic.

“India has saved humanity from a big disaster by containing [Covid-19] effectively,” Narendra Modi, its prime minister, boasted to January’s online World Economic Forum in Davos.

“I thought, ‘We’ve done our bit,’ ” Poonawalla says wryly. “We’d struggled through 2020 to get everything ready. I thought I could put my feet up and take a vacation, but it’s been the exact opposite. It’s been chaotic.”

Modi was guilty of hubris. Since March Covid-19 has raged across India like “a tornado”, says Poonawalla. The country’s health system has all but collapsed. Its cities are designating parks and car parks for funeral pyres, but running out of wood.

Amazingly the government has continued to permit election rallies, test matches and religious festivals like the Kumbh Mela, which attracts millions of pilgrims. The novelist Arundhati Roy has accused Modi’s administration of an “outright crime against humanity”, but Poonawalla declines an invitation to apportion blame. “If I give you the right answer, or any answer, my head would be chopped off . . . I can’t comment on the elections or Kumbh Mela. It’s too sensitive,” he says before adding: “I don’t think even God could have forecast it was going to get this bad.”




The institute is now being accused of profiteering. Hitherto it has sold all its supplies to the government at a price of 150 rupees ($2) per dose, which barely covered its costs. From next week it can sell half its production to states and private hospitals, and will charge 300 rupees ($4) a dose to the former and 600 rupees ($8) to the latter. Poonawalla calls the profiteering charge “totally incorrect”. He acknowledges the institute will make money from the higher price, but insists Covishield will still be “the most affordable vaccine on the planet”.

Poonawalla finds himself in a unique and remarkable position as mankind fights the most deadly pandemic of modern times, one that has already cost more than three million lives. “I’ve always had this sense of responsibility to India and the world because of the vaccines we were making, but never have we made a vaccine so needed in terms of saving lives,” he says.

The pressures are correspondingly enormous. He will not say if Modi calls him in person, but acknowledges regular conversations “at the highest levels” of government. He occasionally plays tennis to relax, but no longer dares to ride for fear of injuring himself. “It’s very stressful. There’s no other way to describe it. There’s no silver bullet. We just have to manage the situation and save as many lives as we can,” he says. At times “I’ve struggled, I tell you. It’s been a rollercoaster of a ride . . . I’ve lost a lot of hair, to say the least.”

Initially he felt “a proud sense and feeling that people were depending on me, and I was doing my best to save and protect the nation and the world”, but he admits feeling disheartened by what he describes as the present negativity towards the institute. Despite all the “sweat and tears”, instead of being “appreciated and supported”, he complains, “we are being vilified and blamed”.

He hopes that posterity will judge him more favourably. “That’s what calms me down,” he says. “We have done the best we can without cutting corners or doing anything wrong or profiteering. I’ll wait for history to judge.” In the meantime, he hopes other Indian vaccine manufacturers will step forward in coming months so “people will forget about me”.




https://www.thetimes.co.uk/article/adar-poonawalla-aggression-over-covid-vaccines-is-overwhelming-everyone-expects-to-get-theirs-first-bfqbgcm96

*Today's top news: 02 May*

1. *On May 1, 2021, India celebrated four hundredth Prakash Purab of Guru Tegh Bahadur.* He was the ninth Sikh Guru. He was born in Amritsar, Punjab in 1621. He was the youngest son of Guru Hargobind Sahib.
He wrote 115 hymns that were included in Guru Granth Sahib. Guru Tegh Bahadur was executed on the orders of Aurangazeb.

2. *Third phase of COVID-19 vaccination begins* : Everyone above the age of 18 years will be administered the COVID-19 vaccine in this phase. The registration process for this phase is on and over 2.66 crore people have registered on the Co-Win portal so far. The appointments for people aged 18 years and above has also opened at multiple locations.

3. *Counting of votes in Tamil Nadu - along with three other states of West Bengal, Kerala, Assam and the Union Territory of Puducherry - will start at 8 AM on 2nd May. Today*

4. Indian Railway has waived of charges for Covid testing and diet supplied during Covid related hospitalisation for non Railway patients .

5. *Ready To Lead Congress Again?" Rahul Gandhi Was Asked. His Response* . There have been demands by the ''Group of 23'' leaders for early organisational elections and a full-time Congress president.
Congress leader Rahul Gandhi on Saturday said he favours internal elections within the party and it will be the workers who will decide who should lead the party and asserted that he will do whatever the party asks him to.

6. *The National Investigation Agency has charged 34 naxalites in connection with the killing of four police personnel in Latehar district of Jharkhand.* The case pertains to the deadly attack on the police pat rolling party by the naxalites on November 22 2019 in which four police personnel were martyred.

7. *The Civil Aviation Ministry on Friday permitted the Telangana government to use drones for experimental delivery of vaccines within the visual line of sight* .

8. Senior Samajwadi leader Mohammad Azam Khan, 72-year-old Rampur MP tested positive for COVID-19 along with 13 other prisoners in Sitapur jail.

9. Delhi lockdown extended by 1 week: tweets CM Arvind Kejriwal.

10. Jailed former RJD MP Mohammad Shahabuddin died of COVID-19 at DDU Hospital on Saturday,

11. BJP MP Gautam Gambhir will now provide 200 oxygen concentrators to those having mild or moderate symptoms of the infection in the national capital.

12. *Congress leader Rahul Gandhi on Saturday launched a medical advisory helpline to help those battling Covid-19. call +919983836838 for medical advice."*

13. The Assam government on Friday extended the night curfew till May 7, following a surge in Covid-19 cases in the state. The restrictions on movement of individuals from 8 pm to 5 am were to end on Saturday

14. India Saturday received a shipment of Russias Covid-19 vaccine Sputnik V as the first batch of 1,50,000 doses landed in Hyderabad from Moscow.

15. *The Central Board of Secondary Education (CBSE) on Saturday announced a policy for tabulation of marks for class 10 board exams* which have been cancelled in view of the COVID-19 pandemic situation in the country. According to the policy, while 20 marks for each subject will be for internal assessment as every year, 80 marks will be calculated on basis of the students' performance in various tests or exams throughout the year. results to be announced by June 20.

16. Days after making an appeal to the government to make education free of cost till graduation for kids who have lost their loved ones to Covid-19, Actor Sonu Sood has yet again requested the government and concerned organisations to come together and make cremation grounds free of cost, enabling people who cannot afford the charges a chance to cremate their loved ones in a proper and respectful manner.

17. Legendary playback singer Lata Mangeshkar has contributed Rs seven lakh to Maharashtra Chief Minister's relief fund to help combat the coronavirus pandemic in the state.

18. Helping the nation in fight against COVID-19, *the Indian Air Force (IAF) carried out 23 sorties from abroad, airlifting 40 oxygen containers,* informed Union Defence Minister, Rajnath Singh.

19. *The Indian Navy has launched Operation Samudra Setu-II* to help in providing assistance in the ongoing national mission for meeting the Oxygen requirements. Under this mission, the Indian Naval warships are going to be undertaking shipment of “liquid Oxygen filled cryogenic containers.

20. *'Co-Jeet' over Covid* : *This is a war, we need to win, says Deputy Chief Integrated Defence Staff* As the younger population of the nation becomes eligible for a vaccination against coronavirus today on Saturday, the armed forces have formulated a plan to aid the inoculation drive and anti-Covid efforts across the nation by providing health requirements of various states --transporting oxygen, ensuring nursing and medical assistance.

*✈INTERNATIONAL NEWS*

1. *Airlines add flights out of ravaged India to bring citizens home*
International and domestic airlines are adding flights out of India to bring home residents and citizens as the nation’s coronavirus outbreak goes from bad to worse. Air India Ltd. plans to increase its weekly frequency of flights to the U.S. to 32 starting May 11.

2. *India extends internation flight suspension till May 31*
Amidst rising COVID-19 cases in India, the country extended the suspension on international commercial flight operations till May 31, 2021. “In partial modification of circular dated 26-06-2020, the competent authority has further extended.

3. US President Joe Biden is sending top American diplomat Daniel Smith as its interim envoy to India amidst the unfolding humanitarian crisis in the country to spearhead close cooperation with it and ensure the two nations continue to advance their shared priorities, including overcoming the Covid-19 pandemic.

4. *Need "Full And Sincere" Disengagement: India To China On Border Issues* India has asked China to ensure "full and sincere" implementation of an agreement between the two nations for complete disengagement from all friction points in eastern Ladakh.

5. *As the second Covid wave ravages the country, the soldiers are sitting tight in Ladakh while monitoring Chinese activity through physical means* besides drones and satellite imagery even as various infrastructure development activities are on to cater to enhanced troop levels and future exigencies.

6. *U.S. okays proposed sale of six P-8I patrol aircraft to India*
The U.S. State Department approved the proposed sale of six P-8I patrol aircraft and related equipment, a deal estimated to cost $2.42 billion. In November 2019, the Defence Acquisition Council, chaired by Defence Minister Rajnath Singh, approved the procurement of the long-range maritime.

7. *The Prime Minister Narendra Modi and the Russian President Vladimir Putin recently agreed to establish “2+2 Ministerial Dialogue* ”. The “2+2 Ministerial” dialogue is held between the defence ministers and foreign ministers.

8. *The countries had earlier set a trade target of reaching 30 billion USD of trade by 2025.* The dialogue will help them achieve the target. Previously, the countries agreed to establish the International North-South Transport Corridor, cooperation at the Eurasian Economic Union and Chennai-Vladivostok Maritime Corridor. The Astronauts shortlisted for the Human Space Flight Programme of India were trained by Russia. The Nuclear Power Plant that is being built in Kudankulam in Tamil Nadu is built with Russian Cooperation. India recently approved Russia’s Sputnik V. It is the third vaccine to be approved in the country after COVAXIN and COVISHIELD.

9. India holds similar dialogues with US, Australia and Japan.
Russia is the first non-QUAD member with which India is to hold the dialogue. In 2021, President Vladimir Putin is to visit India to hold the India-Russia bilateral summit. The summit is alternatively held in India and Russia.

10. Israelis will not be allowed to travel to Ukraine, Brazil, Ethiopia, South Africa, India, Mexico and Turkey.

11. *Colonel Inderjit Singh has been promoted to a Brigadier General, making him the senior most ranking serving Sikh in the Malaysian armed forces.* On 16 April, he took over as the commandant of the Army Senior Officers Institute based in Port Dickson, Negeri Sembilan. The one-star general is the only serving Sikh general in the Malaysian armed forces at this juncture. He is also the fifth Sikh to make it as general in the history of the Malaysian Armed Forces.

*🌎WORLD NEWS🌍*

1. *The final phase of ending America’s “forever war” in Afghanistan after 20 years formally began Saturday,* with the withdrawal of the last US and NATO troops by the end of summer.

2. *International community raises concern over China's coast guard law,* calling it verbal threat
International public opinion has raised concern over the oppressive Coast Guard Law of China, saying that Beijing uses the law to legalise its coast guard force's use of violence to serve the country's unilateral sovereignty claim in the East Sea (also known as the South China Sea).

3. *United States top diplomat Antony Blinken to visit Ukraine next week* .

4. *Myanmar & China’s non-war military activities* : Since February 1, the attention of the world is drawn particularly to two countries, firstly to Myanmar due to the coup d’état and then to its ally China because of its close involvement in that nation through non-war military activities for a long period of time.

5. *Joe Biden’s 100 Days: Key Foreign Policy* Challenges and Initiatives
Considerable significance is attached to the anniversary marking the first hundred days of any US administration. At this juncture, the Biden administration has undertaken a host of initiatives in the domain of US foreign policy despite facing numerous challenges on the domestic front exacerbated by the COVID pandemic.

6. *The United Kingdom is to cut its fund to the United Nations Global Family Planning Programme.* According to the UN Population Fund, the UK had pledged 154 million Euros. However, now UK is to provide only 23 million Euros.

7. *Russia recently produced the first batch of COVID-19 vaccines for animals. The name of the vaccine is Carnivac-Cov.*

8. *The Government of Germany recently announced that it is to return the artefacts called the “Benin Bronzes” to Nigeria* . The “Benin Bronzes” are currently held in the museum of Germany. They are a group of thousand metal sculptures. These sculptures once decorated the royal palace of Kingdom of Benin, the current Nigeria. Some of these sculptures were looted by the British during the Benin Expedition of 1897

*🚣🚴🏇🏁🏊Sports:*

1. *IPL Match 27* Saturday, 1st May 2021
MUMBAI INDIANS 219/6
Vs
CHENNAI SUPER KINGS 218/4
*Mumbai Indians won by 4 wickets*
Arun Jaitley Stadium, Delhi

2. *IPL : Match 28*
Sunday, 2nd May 2021

RAJASTHAN ROYALS
VS
SUNRISERS HYDERABAD

15:30 IST (10:00 GMT)
Arun Jaitley Stadium, Delhi

3. *Match 29*
PUNJAB KINGS
Vs
DELHI CAPITALS

19:30 IST (14:00 GMT)
Narendra Modi Stadium, Ahmedabad

*USD 74.69 💷GBP 102.37*
_In Kolkata (WB)_
*🥇Gold ₹48,150@10 gm 24 (Krt)*
🥈 *Silver ₹67,580@ Kg*
⛽ *Petrol ₹ 90.62*
⛽ *Diesel ₹ 83.61*

*LPG : ₹ 835.50 /14.2 Kg*

*BSE Sensex* 48,782.36
*NIFTY* 14, 631.10

*🇮🇳Facts about India🇮🇳*

Seven Sister States of India
Arunachal Pradesh.
Assam.
Manipur.
Meghalaya.
Mizoram.
Nagaland.
Tripura.

*😀Thought of the day*

B4 u speak listen,
B4 u write think,
B4 u spend earn,
B4 u criticise wait,
B4 u pray forgive,
B4 u quit try,

*Joke of the day*

Today, u know what happened in our colony!😄

My friend got too bored by sitting at home...😰

So, he went out n told the outside vegetable cart puller...

Thus, it’s customary to offer whatever is poisonous to Bhagwan Shiv. So the Hindus offer milk over shivling (Sanskrit for symbol of Shiv) during the month of Shravan as it is considered akin to a poison by the science of Ayurved.

Hinduism says “Feed to others only what you can eat for yourself (Which means, do not offer to others what you will never consume), always give the best to others and do welfare for all. Always take care of the poor and feed them the fresh and healthy food”-(From the Vedas).
Now if we feed the milk or green leafy vegetables, which is poison during the Shravan, then it’s a sin as it will cause them diseases.

🧬 *HEALTH CARE: HOME REMEDIES*🩺
( *Note* : These home tips followed in villages/ancient traditions, it is up to you to use it or not🙏🏻)

*Corn* has several health benefits. Because of the high fiber content, it can aid with digestion. It also contains valuable B vitamins, which are important to your overall health. Corn also provides our bodies with essential minerals such as zinc, magnesium, copper, iron and manganese.

*Regards*

*🙏PLZ FOLLOW GOVT. NORMS, MAINT SOCIAL DISTANCE, KEEP YOURSELF & YOUR FAMILY SAFE🌼*


https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*

“Can you please sit in my house n watch TV for some time...?? I will take your vegetable cart for a couple of rounds and sell them for you...”

Vegetable cart puller said : 🤫

“ Sir, I am a software engineer from the next cross...The original vegetable vendor is sitting in my house n watching TV” 🤪😂😂

💁🏻‍♂️ *GK TODAY*

The World largest airplane built by Stratolaunch. top speed of 320 kilometre per hour. The plane can carry more than 220 tonnes of payload. The wingspan of the aircraft is 117 metres. This is greater than an American football field. *It has been named “Roc”.* Roc is an enormous bird usually addressed in the mythological stories of the Middle East. It is quite popular from “Sinbad, the Sailor”.

*Why ....* ⁉️

⁉ *Why are most famous (or wish fulfiling) temples situated on hills?*

We generally feel that that a temple near our house is a normal temple while that on a particular hill is a special temple

Scientific Reason :

Cosmic energy level is high on this altitude.
Aura (If you understand this term) at such altitudes is very positive.
Atmosphere is also much clean. People makes efforts to reach it with a positive thoughts.

*LEARN Sanskrit*🙏🏻

*कपोतः* - कबूतर
*अश्वः* - घोडा

🤔 *How it works* ⁉

*Making of Paintbrush* :The filament may be either of animal hair and is most often of long-haired hog bristle, often referred to simply as bristle. Other natural animal hairs used in American brushes include squirrel, goat, ox, badger, and horse-hair. The most expensive animal-hair brushes are hand-made of sable. Synthetic filament used in paintbrushes are produced by extrusion (in which liquid synthetic is pushed through a mold and thus formed) and may be acrylic, polyester, nylon or amalon which is a very inexpensive petroleum-based synthetic. Different synthetics perform better with different kinds of paint so a painter should know the filament material as he or she chooses brushes. Synthetic filament may be of three constructions: solid extrusion, "x-shaped," or hollow. Solid extrusion synthetic filament lasts the longest and cleans up the easiest. X-shaped filament gives good performance and is a bit cheaper than solid filament. The hollow filament wears out quickly and is difficult to clean but is quite inexpensive. Consumer-grade paintbrushes may be of hog bristle or synthetic filament; however, water-based paints, such as latex, perform better when synthetic filament is used

🛕 *VEDIC GYAN*

*Why do Hindus pour milk on Shivling during the month of Shravan?“*

Few people argue that
the amount of milk ‘wasted’ on such a day can feed thousands of poor instead. Why this ‘excess’ then?

Now having said that, let’s examine the beliefs and logic behind such act and how right or wrong it is to call anyone a fool for following the custom.

According to the science of Ayurveda, every person has 3 components in them:
1) Vata (Air)
2) Kafa (Cough) and
3) Pitta (Acids)

All three elements are necessary for smooth functioning of our body. However, when the proportion of these components goes out of natural balance, the body begins to suffer under various ailments.

During the month of Shravan, the Vata component of a person gets higher in proportion. During that period, a person must avoid food that increases the Vata component. For example, green leafy vegetable contain higher amounts of Vata in them. [Jains also have Paryushan during this time and avoid green vegetables]
Thus a person is asked to avoid them during the rainy season (especially Shravan month) to avoid the ailments caused due to excess of Vata.
During the rainy season, the cattle also eat lots of green grass, and hence their milk is high in Vata and, in modern times, is succeptible to viral infections. Hence, milk is considered harmful during the Shravan month. Thus Ayurved advices us against consuming milk during Shravan..In Sanatan Dharm, Bhagwan Shiv is known to consume the poison which came out during Samudra Manthan (Churning of the Oceans).

*TOWER TALK*

ICICI Bank’s Q4 zoomed 260% to Rs. 4402.61 cr. on the back of big rise in interest income and the bank declared a dividend of Rs. 2/ share. A good long-term investment.

Coal India remains a good investment bet as 57% of our electricity production is coal based. A good dividend yield is the icing on the cake. Add.

Mishra Dhatu Nigam has large orders from defence, space, atomic energy and aeronautics. With the rising allocations to this sector, this share is a good add.

Multiple positives and a reasonable valuation makes Alkem Laboratories an exciting investment. It has over 100 approvals on hand and many more in the pipeline.

Natco Pharma awaits approval for Molnupiravir capsules to treat Covid-19. Clinical trials show that it needs to be administered for 5 days only, which can be a big positive for the Company.

Biocon Biologics has received CHMP nod for Abevmy, a bio similar for the treatment of ovarian, colorectal, breast, lung, cervical and renal cancers. Its Q4 profits, too, surged 86% to Rs. 296 cr. Buy.

ABB, which is into power and automation business, posted 119% jump in Q1FY22 NP at Rs. 141 cr. on just 7% higher revenue of Rs. 1629.15 cr. Add.

Axis Bank’s excellent turnaround with Q4FY21 profit of Rs. 2677 cr. from a net loss of Rs. 1387.78 cr. in Q4FY20 qualifies for a round of fresh investment.

Considering the Covid surge, Britannia’s 3% dip in profit is fairly good. Retain this share as it may bounce back quickly.

Maruti Suzuki missed targets as Q4FY21 profit fell 9.7% to Rs. 1166 cr. The company is likely to bounce back soon. Do not sell.

M&M has roped in Uli Stuhec to steer its Electric Vehicles portfolio. The leadership talent is likely to continue. Add.

Bajaj Finance Q4 profit surged 42% due to lower borrowing costs and dividend of Rs. 10/share has been declared. The management feels good times may continue in FY22 too. Add.

SBI is likely to raise $ 2 bn (about Rs. 14,942 cr.) via bonds to support its growing business. Its next few quarters are likely to be good. Add.

PNB Housing has turned around with Q4FY21 profit of Rs. 130 cr. against a loss of Rs. 263 cr.in Q4FY20. It also plans to raise Rs. 5800 cr. for its growing business. Add.

TVS Motor’s excellent Q4 with an EPS of Rs.6.09 from Rs. 1.56 in Q4FY20 led to a dividend of 140%. A good long term investment bet.

GHCL’s Q4 profits rose 31% to Rs. 111 cr. on 10.2% rise in sales to Rs. 821 cr. The management is optimistic about the current year too. Add.

The big price rise in Titan Biotech may be a precursor of excellent results in the next few days. It may post an FY21 EPS of Rs. 40+ and its share price may rise another 35% in three months. Add.

Sahyadri Industries has nearly doubled in about 6 months after we recommended it. The share can rise further on Q4 results. Buy this debt-free Company for handsome gains.

As expected, Marico’s Q4 NP has risen 17% to Rs. 238 cr. on a revenue of Rs. 2012 cr. The share price has yet to catch up with bigger peers in the industry. Add.

Although SAIL’s share price has tripled in the last one year, it is a good investment bet considering that steel prices are rising along with the demand.

Laurus Labs posted FY21 EPS of Rs. 18.36 v/s Rs. 4.79 in FY20 makes it an excellent buy especially as the entire industry is faring well. Add.

GHCL has notched 35% higher Q3FY21 EPS of Rs 11.7 and FY21 EPS of Rs 34.2. It’s undergoing an expansion in soda ash and the proposed demerger of the textile and chemical biz is expected to fetch a decent gain of 30% in the medium term.

Prima Plastics, a competitor of Nilkamal Ltd., has notched 123% higher Q3 EPS of Rs 5.2 and 76% higher 9MFY21 EPS of Rs 10.5, which could lead to FY21 EPS of Rs 16 to Rs 20 in FY22. Buy for 50% gain.

Sree Rayalaseema Hypo Strength, manufacturer of chemicals, has posted 64% higher Q3 EPS of Rs 10 and 77% higher 9MFY21 EPS of Rs 27.4 m and may post FY21 EPS of Rs 40, which may rise to up to Rs 45 in FY22 due to the rising demand. The share can gain 30% as the investors have started accumulating this stock. Buy.

Chennai Petroleum Corporation has notched Q4FY21 EPS of Rs 16.3 and Rs 17.3 for FY21 due to higher refinery margins. The share is likely to touch Rs 140 in the short term.

Shakti Pumps, the pioneer of energy-efficient pumps and motors is a prestigious brand in domestic and overseas markets, has posted Q3 EPS of Rs 14.4, 9MFY21 Rs 24.5 is all set to notch FY21 EPS of Rs 42+ and Rs 60 in FY22. Shakti is the most preferred Solar Energy Brands. Buy for 30% appreciation.

Samkrg Pistons & Rings, which made a lifetime high of Rs 379 on 15 Jan 2018, exports 25% products to over 24 countries has notched Q3 EPS of Rs 7.6 and could post FY21 EPS of Rs 18 on the revival of the auto sector. The share may cross the Rs 200 mark. Buy.

Welspun Corp has sold its plates and coil mills division to JSW Steel for Rs 848.5 cr. and will sell its 43 MW power plant to Welspun Power for Rs 66.9 cr. Last month, it won a Rs 777 cr. order from the Middle East and may notch FY21 EPS of Rs 25. Shareholders can expect a hefty dividend. Buy.

IZMO Ltd., a world leader in interactive marketing solutions offering hi-tech automotive e-retailing solutions in North America, Europe, and Asia, has notched 36% higher Q3 EPS of Rs 6.3, 179% higher 9MFY21 EPS of Rs 16.5, which could take its FY21 EPS to Rs 23. The share may rise 100% in the medium to short term. Buy.

Bajaj Steel Industries, perhaps the only company in the world producing machinery for all cotton ginning technologies, has posted Q3 EPS of Rs 33.9 (FV Rs 5), 9MFY21 EPS of Rs 70, which could lead to FY21 EPS of Rs 100.The share is poised to touch Rs 750 at a P/E multiple of 7.5x.

Mangalam Cement, a BK Birla group co, has notched 200% higher Q3 net profit with an EPS of Rs 14, 9MFY21 EPS of Rs 27.2 and is expected to post FY21 EPS of Rs 40. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.

SP Apparels, a fully integrated manufacturer & exporter of knitted garments under the ‘Crocodile’ brand, has notched Q3 EPS of Rs 7.7, 9MFY21 EPS of Rs 15 and is expected to notch FY21 EPS of Rs 23. The share is likely to advance by 30% going forward. Add in the portfolio.

Cigniti Technologies serving 200+ industry active clients including 50 Fortune 500 customers across 13 countries with diversified verticals has posted Q3 EPS of Rs 9.5 and 9MFY21 EPS of Rs 29 is all set to garner FY21 EPS of Rs 42. Buy for 30% appreciation.

Dhunseri Ventures having several subsidiaries and joint ventures has chalked out 45,000 TPA polyester packaging plant for Rs 400 cr. Having posted 9MFY21 consolidated EPS of Rs 32.6, it is grossly underpriced as its sound financials will take its share price to dizzy heights.

UTI Assets Management has posted a 625% higher Q4 EPS of Rs 10.6 and 82% higher FY21 EPS of Rs 39. Having declared 170% dividend (Rs 17/share), the share is expected to gain 20% going forward.

Sugar is the next Steel according to market pundits. Magadh Sugar recommended two weeks back @ Rs.110 hit a high of Rs.172 on Friday.

JK Tyre has reduced its debt substantially and its rating has been upgraded. It is likely to come out with exceptionally good quarter with an EPS of Rs.10. The stock trades cheap at Rs.120 and can easily appreciate 50% from the current levels.

Tilaknagar Industries, manufacturer of Mansion House Brandy, has signed a long-term deal with global spirits giant Pernod Ricard to manufacture its product. A long term positive for the stock. Buy for multi-bagger gains.

NSE listed Sundaram Finance Holdings (Rs.74) is likely to apply to RBI for an NBFC licence. The stock trades cheap at a market cap of less than Rs. 2000 cr. and can give multi-bagger returns to a patient investor. Buy at every decline.

Themis Medicare is celebrating its Golden Jubilee and is likely to post FY21 EPS of Rs. 40. The stock is trading at an attractive P/Evaluation of just 9 and has the potential to rise 50% in the short term

Filatex recommended last week is up 20%

Dhampur Sugar recommended last week is up 25%